Image

Global At-Home Testing Kits Market – Industry Trends and Forecast to 2031

Healthcare

Image

Global At-Home Testing Kits Market – Industry Trends and Forecast to 2031

  • Healthcare
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, Other Test Types), Type (Cassette, Strip, Midstream, Test Panel, Dip Card, Other Form Types), Age (Pediatric, Adult, Geriatric), Sample Type (Urine, Blood, Saliva, Others), Usage (Disposable, Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket,  Online Pharmacies) - Industry Trends and Forecast to 2031.

At-Home Testing Kits Market

At-Home Testing Kits Market Analysis and Size

At-home testing kits are testing instruments that help a person perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of the diabetic patient. At-home tests are very convenient to perform with comfort at home and are available at a very affordable rate. Self-tests are usually the advanced versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by the common person.

Data Bridge Market Research analyzes that the global at-home testing kits market which was USD 7.44 billion in 2023, is likely to reach USD 11.95 billion by 2031, and is expected to undergo a CAGR of 6.1% during the forecast period. “Portable devices" dominate the distribution channel segment of the market due to increasing awareness of proper treatment. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, Other Test Types), Type (Cassette, Strip, Midstream, Test Panel, Dip Card, Other Form Types), Age (Pediatric, Adult, Geriatric), Sample Type (Urine, Blood, Saliva, Others), Usage (Disposable, Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket,  Online Pharmacies)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of the Middle East & Africa

Market Players Covered

Abbott (U.S.), Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd (Switzerland), BD (Becton, Dickinson and Company) (U.S.), Drägerwerk AG & Co. KGaA (Germany) , LifeScan IP Holdings, LLC (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Nectar Lifesciences Ltd. (Rapikit) (India), ACON Laboratories, Inc. (U.S.), Quidel Corporation (U.S.), ARKRAY USA, Inc. (U.S.), BTNX INC. (Canada), Atomo Diagnostics (Australia), Eurofins Scientific (Luxembourg), Piramal Enterprises Ltd. (India), Bionime Corporation (Taiwan), Nova Biomedical (U.S.), Cardinal Health (U.S.), OraSure Technologies (U.S.), Biolytical Laboratories Inc. (Canada), Everlywell, Inc. (U.S.), SA Scientific Ltd. (U.S.), Clearblue (a subsidiary of Swiss Precision Diagnostics GmbH) (U.K.), Biosynex (France), PRIMA Lab SA (Switzerland), MP BIOMEDICALS (U.S.), Sterilab Services (France), Chembio Diagnostics, Inc. (U.S.), BioSure (U.K.), Selfdiagnostics OU (Estonia)

Market Opportunities

  • Telehealth Integration
  • Technological Advancements

Market Definition

At-home testing kits, also known as home test kits or home diagnostic kits, are medical or health-related devices that allow individuals to perform specific tests or screenings for various conditions or diseases within the comfort of their own homes. These kits typically include necessary tools, instructions, and sometimes, prepaid packaging to send the collected samples back to a laboratory for analysis. At-home testing kits are designed to provide convenient and private ways for individuals to monitor their health, assess certain biomarkers, or detect specific health conditions without visiting a healthcare facility. These kits are commonly used for various purposes, such as pregnancy tests, blood glucose monitoring, DNA testing, sexually transmitted infection (STI) tests, and more.

Global At-Home Testing Kits Market Dynamics

Drivers

  • Growing Adoption of Self-Testing Kits

Earlier, people used to visit hospitals often, even for basic problems. However, as awareness has grown regarding several products, this behaviour has changed and has turned the trend. Nowadays, people prefer to get their basic tests done using test kits at home before visiting a doctor. This has become even more prominent due to this pandemic as people are adopting more self-help testing kits due to several restrictions in place. It has turned out to be a boon in disguise for both hospitals and patients as hospitals are already stretched thin and can entirely focus on COVID-19 patients, and the patients can save hefty costs of doctor visits and medicine fees. It has become highly convenient for consumers as they can quickly know their tests' results at their fingertips.

  • Testing Easy Availability of Self-Testing Kits at Pharmacies

At-home or self-testing kits are easily available at pharmacies, and it has become effortless to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits. This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription.

Opportunities

  • Telehealth Integration

The growing adoption of telehealth services presents an opportunity for at-home testing kits. Integrated telehealth platforms can streamline the process of obtaining test results, consultations, and further medical guidance.

  • Technological Advancements

Advances in technology, especially in the fields of diagnostics and biosensors, have led to the development of more accurate and user-friendly at-home testing kits. Improved accuracy, simplicity, and speed contribute to the market's growth.

Restraints/Challenges

  • Regulatory Challenges

Stringent regulatory requirements for the approval of at-home testing kits can pose a challenge for manufacturers. Navigating complex regulatory landscapes may slow down the introduction of new products to the market.

  • Limited Test Offerings

Some complex diagnostic tests may not be feasible for at-home use, limiting the scope of testing kits. Certain medical conditions may still require laboratory-based tests for accurate results.

Global At-Home Testing Kits Market Scope

The at-home testing kits market is segmented into six notable segments based on test type, type, age, sample type, usage, and distribution channels. The growth amongst these segments will help you analyze market growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

  • Pregnancy Test
  • HIV Test Kit
  • Diabetes
  • Infectious Diseases
  • Glucose Tests
  • Ovulation Predictor Test Kit
  • Drug Abuse Test Kit
  • Others

Type

  • Cassette
  • Strip
  • Midstream
  • Test Panel
  • Dip Card
  • Others

Age

  • Pediatric
  • Adult
  • Geriatric

Sample Type

  • Urine
  • Blood
  • Saliva
  • Others

 Usage

  • Disposable
  • Reusable

 Distribution Channels

  • Retail Pharmacies
  • Drug Store
  • Supermarket/Hypermarket
  • Online Pharmacies

 At-Home Testing Kits Market Regional Analysis/Insights

The at-home testing kits market is analyzed and market size insights and trends are provided based on test type, type, age, sample type, usage, and distribution channels as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Switzerland, Russia, Turkey, Belgium, rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E, Israel, Egypt, and rest of Middle East and Africa.

North America is expected to dominate and show the fastest growth in the market due to the region's high healthcare expenditure and the increasing awareness about the at-home testing kits market.

The country section of the report also provides individual market impacting factors and domestic regulation changes that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.     

Healthcare Infrastructure growth Installed base and New Technology Penetration

The at-home testing kits market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for  at-home testing kits market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on  at-home testing kits market. The data is available for historic period 2010-2020.

Competitive Landscape and At-Home Testing Kits Market Share Analysis

The at-home testing kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to at-home testing kits market.

Some of the major players operating in the at-home testing kits market are:

  • Abbott (U.S.)
  • Siemens Healthcare GmbH (Germany)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • BD (Becton, Dickinson and Company) (U.S.)
  • Drägerwerk AG & Co. KGaA (Germany)
  • LifeScan IP Holdings, LLC (U.S.)
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • Nectar Lifesciences Ltd. (Rapikit) (India)
  • ACON Laboratories, Inc. (U.S.)
  • Quidel Corporation (U.S.)
  • ARKRAY USA, Inc. (U.S.)
  • BTNX INC. (Canada)
  • Atomo Diagnostics (Australia)
  • Eurofins Scientific (Luxembourg)
  • Piramal Enterprises Ltd. (India)
  • Bionime Corporation (Taiwan)
  • Nova Biomedical (U.S.)
  • Cardinal Health (U.S.)
  • OraSure Technologies (U.S.)
  • Biolytical Laboratories Inc. (Canada)
  • Everlywell, Inc. (U.S.)
  • SA Scientific Ltd. (U.S.)
  • Clearblue (a subsidiary of Swiss Precision Diagnostics GmbH) (U.K.)
  • Biosynex (France)
  • PRIMA Lab SA (Switzerland)
  • MP BIOMEDICALS (U.S.)
  • Sterilab Services (France)
  • Chembio Diagnostics, Inc. (U.S.)
  • BioSure (U.K.)
  • Selfdiagnostics OU (Estonia)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The At-Home Testing Kits Market size will be worth USD 11.95 billion by 2031 during the forecast period.
The At-Home Testing Kits Market growth rate is 6.1% during the forecast period.
The Testing Easy Availability of Self-Testing Kits at Pharmacies and Growing Adoption of Self-Testing Kits are the growth drivers of the At-Home Testing Kits Market.
The test type, type, age, sample type, usage, and distribution channels are the factors on which the At-Home Testing Kits Market research is based.
The major companies in the At-Home Testing Kits Market are Abbott (U.S.), Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd (Switzerland), BD (Becton, Dickinson and Company) (U.S.), Drägerwerk AG & Co. KGaA (Germany) , LifeScan IP Holdings, LLC (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Nectar Lifesciences Ltd. (Rapikit) (India), ACON Laboratories, Inc. (U.S.), Quidel Corporation (U.S.), ARKRAY USA, Inc. (U.S.), BTNX INC. (Canada), Atomo Diagnostics (Australia), Eurofins Scientific (Luxembourg), Piramal Enterprises Ltd. (India), Bionime Corporation (Taiwan), Nova Biomedical (U.S.), Cardinal Health (U.S.), OraSure Technologies (U.S.), Biolytical Laboratories Inc. (Canada), Everlywell, Inc. (U.S.), SA Scientific Ltd. (U.S.), Clearblue (a subsidiary of Swiss Precision Diagnostics GmbH) (U.K.), Biosynex (France), PRIMA Lab SA (Switzerland), MP BIOMEDICALS (U.S.), Sterilab Services (France), Chembio Diagnostics, Inc. (U.S.), BioSure (U.K.), Selfdiagnostics OU (Estonia).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials